Cyclocryotherapy employs temperatures as low as-112 °F (-80 °C) to destroy the ciliary body, thereby decreasing aqueous production and intraocular pressure. Secondary to the risk of significant intraocular inflammation, loss of vision, and phthisis, cyclocryotherapy may often be used as a last-line treatment option for uncontrolled or refractory glaucoma.
CITATION STYLE
Wandel, T., & Nattis, A. S. (2021). Cyclocryotherapy. In Operative Dictations in Ophthalmology: Second Edition (pp. 289–290). Springer International Publishing. https://doi.org/10.1007/978-3-030-53058-7_61
Mendeley helps you to discover research relevant for your work.